These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 27788146)

  • 1. A Systematic Review of Biomarkers and Risk of Incident Type 2 Diabetes: An Overview of Epidemiological, Prediction and Aetiological Research Literature.
    Abbasi A; Sahlqvist AS; Lotta L; Brosnan JM; Vollenweider P; Giabbanelli P; Nunez DJ; Waterworth D; Scott RA; Langenberg C; Wareham NJ
    PLoS One; 2016; 11(10):e0163721. PubMed ID: 27788146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of plasma proteomics with incident coronary heart disease in individuals with and without type 2 diabetes: results from the population-based KORA study.
    Luo H; Huemer MT; Petrera A; Hauck SM; Rathmann W; Herder C; Koenig W; Hoyer A; Peters A; Thorand B
    Cardiovasc Diabetol; 2024 Feb; 23(1):53. PubMed ID: 38310303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mendelian randomization studies of biomarkers and type 2 diabetes.
    Abbasi A
    Endocr Connect; 2015 Dec; 4(4):249-60. PubMed ID: 26446360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prioritising Risk Factors for Type 2 Diabetes: Causal Inference through Genetic Approaches.
    Wittemans LBL; Lotta LA; Langenberg C
    Curr Diab Rep; 2018 May; 18(7):40. PubMed ID: 29779155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of circulating NMR metabolic biomarkers for type 2 diabetes risk in the UK Biobank study.
    Bragg F; Trichia E; Aguilar-Ramirez D; Bešević J; Lewington S; Emberson J
    BMC Med; 2022 May; 20(1):159. PubMed ID: 35501852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomics Signatures in Type 2 Diabetes: A Systematic Review and Integrative Analysis.
    Sun Y; Gao HY; Fan ZY; He Y; Yan YX
    J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 31782507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver aminotransferases and risk of incident type 2 diabetes: a systematic review and meta-analysis.
    Kunutsor SK; Apekey TA; Walley J
    Am J Epidemiol; 2013 Jul; 178(2):159-71. PubMed ID: 23729682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intake of dietary fats and fatty acids and the incidence of type 2 diabetes: A systematic review and dose-response meta-analysis of prospective observational studies.
    Neuenschwander M; Barbaresko J; Pischke CR; Iser N; Beckhaus J; Schwingshackl L; Schlesinger S
    PLoS Med; 2020 Dec; 17(12):e1003347. PubMed ID: 33264277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers for predicting type 2 diabetes development-Can metabolomics improve on existing biomarkers?
    Savolainen O; Fagerberg B; Vendelbo Lind M; Sandberg AS; Ross AB; Bergström G
    PLoS One; 2017; 12(7):e0177738. PubMed ID: 28692646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations among circulating sphingolipids, β-cell function, and risk of developing type 2 diabetes: A population-based cohort study in China.
    Yun H; Sun L; Wu Q; Zong G; Qi Q; Li H; Zheng H; Zeng R; Liang L; Lin X
    PLoS Med; 2020 Dec; 17(12):e1003451. PubMed ID: 33296380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between multimorbidity, all-cause mortality and glycaemia in people with type 2 diabetes: A systematic review.
    Chiang JI; Jani BD; Mair FS; Nicholl BI; Furler J; O'Neal D; Jenkins A; Condron P; Manski-Nankervis JA
    PLoS One; 2018; 13(12):e0209585. PubMed ID: 30586451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen activator inhibitor-1 and type 2 diabetes: a systematic review and meta-analysis of observational studies.
    Yarmolinsky J; Bordin Barbieri N; Weinmann T; Ziegelmann PK; Duncan BB; Inês Schmidt M
    Sci Rep; 2016 Jan; 6():17714. PubMed ID: 26813008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precision prognostics for cardiovascular disease in Type 2 diabetes: a systematic review and meta-analysis.
    Ahmad A; Lim LL; Morieri ML; Tam CH; Cheng F; Chikowore T; Dudenhöffer-Pfeifer M; Fitipaldi H; Huang C; Kanbour S; Sarkar S; Koivula RW; Motala AA; Tye SC; Yu G; Zhang Y; Provenzano M; Sherifali D; de Souza RJ; Tobias DK; ; Gomez MF; Ma RCW; Mathioudakis N
    Commun Med (Lond); 2024 Jan; 4(1):11. PubMed ID: 38253823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomics of Type 1 and Type 2 Diabetes.
    Arneth B; Arneth R; Shams M
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31109071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers for type 2 diabetes.
    Laakso M
    Mol Metab; 2019 Sep; 27S(Suppl):S139-S146. PubMed ID: 31500825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic biomarkers to identify patients likely to develop severe Crohn's disease: a systematic review.
    Halligan S; Boone D; Archer L; Ahmad T; Bloom S; Rodriguez-Justo M; Taylor SA; Mallett S
    Health Technol Assess; 2021 Jul; 25(45):1-66. PubMed ID: 34225839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarker-defined pathways for incident type 2 diabetes and coronary heart disease-a comparison in the MONICA/KORA study.
    Huth C; Bauer A; Zierer A; Sudduth-Klinger J; Meisinger C; Roden M; Peters A; Koenig W; Herder C; Thorand B
    Cardiovasc Diabetol; 2020 Mar; 19(1):32. PubMed ID: 32164753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of cardiac stress biomarkers with incident type 2 diabetes and changes in glucose metabolism: KORA F4/FF4 study.
    Sujana C; Seissler J; Jordan J; Rathmann W; Koenig W; Roden M; Mansmann U; Herder C; Peters A; Thorand B; Then C
    Cardiovasc Diabetol; 2020 Oct; 19(1):178. PubMed ID: 33066780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-Response Relationship between Dietary Magnesium Intake and Risk of Type 2 Diabetes Mellitus: A Systematic Review and Meta-Regression Analysis of Prospective Cohort Studies.
    Fang X; Han H; Li M; Liang C; Fan Z; Aaseth J; He J; Montgomery S; Cao Y
    Nutrients; 2016 Nov; 8(11):. PubMed ID: 27869762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.